跳至主要内容
临床试验/NCT05165979
NCT05165979进行中(未招募)不适用

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil

Hospital Moinhos de Vento24 个研究点 分布在 1 个国家目标入组 650 人开始时间: 2021年12月21日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
650
试验地点
24
主要终点
One-year utility score of health related quality of life

研究概览

简要总结

The present prospective cohort study aims to assess factors associated with of one-year health-related quality of life and physical, cognitive and mental health outcomes among adult survivors of hospitalization for COVID-19. Adult patients requiring hospitalization due to COVID-19 disease will be followed through structured and centralized telephone interviews performed at 3, 6, 9 and 12 months after enrollment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years;
  • Symptomatic COVID-19 disease within the last 14 days;
  • Positive polymerase chain reaction (PCR) test for SARS-CoV-2 within the last 14 days;
  • Need of hospitalization (duration ≥ 48 hours).

排除标准

  • Severe comorbidity with life expectancy less than 3 months;
  • Death during hospitalization;
  • Absence of telephone contact;
  • Absence of proxy for patients with communication difficulties;
  • Refusal or withdrawal of agreement to participate;
  • Previous enrollment in the study.

结局指标

主要结局

One-year utility score of health related quality of life

时间窗: The outcome will be assessed 12 months after enrollment.

The outcome will be assessed using the Brazilian version of the Euroqol-5D-3L (EQ-5D3L) questionnaire.

次要结局

  • Instrumental Activities of Daily Living(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
  • Utility score of health related quality of life at 3, 6, and 9 months(The outcome will be assessed at 3, 6, and 9 months after enrollment.)
  • Incidence of major cardiovascular events(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
  • Prevalence of anxiety and depression symptoms(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
  • Incidence of rehospitalizations(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
  • Prevalence of prolonged COVID-19 symptoms(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
  • Prevalence of posttraumatic stress disorder symptoms(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
  • Incidence of return to work or study(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
  • Incidence of all-cause mortality(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
  • Prevalence of cognitive dysfunction(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
  • Incidence of new symptomatic COVID-19 infection(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)
  • Physical functional status(The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验